Compositions and methods for inhibiting expression of CD274/PD-L1 gene
US9422562B2 · kind B2 · utility
5Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2013 |
| Grant date | Aug 23, 2016 |
| Priority date | — |
| Expiry date | Jul 10, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the CD274/PD-L1 gene, and methods of using such dsRNA compositions to inhibit expression of CD274/PD-L1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.